Extrait

1. To establish the response rates to GAMIO 2. To establish the safety and efficacy of substitution of oxaliplatin and irinotecan for cisplatin and etoposide 3. To establish the toxicity of GAMIO 4. To establish progression free survival (PFS) 5. To ascertain whether a repeat FDG PET-CT scan at 14 days (after 1 cycle of therapy but prior to cycle 2) may predict long-term, progression-free survival following GAMIO.

Critère d'inclusion

• Relapsed Germ Cell Tumour with poor prognosis

Liens

• ictrp
• euctr